We showed that serum levels of inflammatory mediators such as MMP-3 and blood mRNA expression of antioxidant enzymes superoxide dismutase (sod1) and catalase (cat) significantly correlated with pain scores in the human early RA cohort. This evidence concerns the gene SOD1 and rheumatoid arthritis.